Market Overview

Corporate Reputation of Pharma Companies, 2017-2018 - The Patient Perspective of 101 Mental Health Patient Groups - ResearchAndMarkets.com

Share:

The "The
Corporate Reputation of Pharma Companies, 2017 - The Patient Perspective
of 101 Mental Health Patient Groups - Mental Health Edition"

report has been added to ResearchAndMarkets.com's
offering

State of relationships between mental-health patient groups and
the pharmaceutical industry

Mental-health patient groups provide pivotal support to patients who are
experiencing issues of mental health. These patient groups will also
typically reach out, and offer help, to the families, carers, and
friends of the individuals with a mental-health issue (indeed, some
mental-health patient groups specialise in representing the interests of
just these latter stakeholders).

Mental-health patient groups train carers, family, and friends in
helping with people living with a mental-health issue - and even train
health professionals. In addition, mental-health patient organisations
do much to raise public awareness of the prejudice shown to people with
a mental-health issue.

Yet, despite the important role played by this component of the patient
movement, data from the mental-health element of the 2017
Corporate-Reputation survey confirms that levels of engagement between
pharma companies and mental-health patient groups are not extensive
(except in the case of a few companies - particularly, Janssen).

So, how did the companies perform at corporate reputation in
2017, in the viewpoints of mental-health patient groups?

Ranking at corporate reputation is measured by patient groups familiar
with a company.

  • Janssen was ranked 1st out of 14 companies in 2017 by
    the 74 mental-health patient groups familiar with it. Janssen has been
    rated in the top position for corporate reputation by mental-health
    patient groups for all three of the years in which the mental-health
    element of the Corporate-Reputation study has been running.
  • Otsuka was featured in the mental-health
    Corporate-Reputation analysis for the first time in 2017, and was
    ranked 2nd out of 14 companies by the 31 mental-health patient groups
    familiar with it. The Japan-headquartered company achieved this high
    ranking by being rated 2nd for eight of the 12 individual indicators
    of corporate reputation.
  • Lundbeck was ranked 3rd out of 14 companies in 2017
    by the 48 mental-health patient groups familiar with it. Lundbeck came
    2nd for four of the 12 individual indicators of corporate reputation.

Key Topics Covered:

  1. Executive Summary
  2. Mental-Health Patient-Group Relationships With Pharma, 2017
  3. Industry-Wide Findings From Mental-Health Patient Groups, 2017
  4. Rankings Of The 14 Pharma Companies, 2017 V. 2016
  5. Among Mental-Health Patient Groups Familiar With The Companies
  6. Positionings Of Nine Pharma Companies, 2017 V. 2016
  7. Among Mental-Health Patient Groups That Work/Partner With The Companies
  8. Profiles Of The 14 Companies, 2017

Companies Mentioned

  • Allergan
  • Astrazeneca
  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • Eli Lilly
  • GSK
  • Janssen
  • Lundbeck
  • Merck & Co / Msd
  • Otsuka
  • Pfizer
  • Roche
  • Sanofi
  • Teva

For more information about this report visit https://www.researchandmarkets.com/research/2t7vkx/corporate?w=4

View Comments and Join the Discussion!